Local Institution - 0058

Sayama, Osaka 589-8511

0 studies enrolling now · 1 studies all time

What they study most

Non-Small-Cell Lung Carcinoma

Studies at this site

• A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy — Completed